How does pelvic inflammatory disease develop?

How Pelvic Inflammatory Disease Develops

PID develops primarily through direct canalicular (ascending) spread of organisms from the endocervix upward to the endometrium and fallopian tubes, most commonly initiated by untreated sexually transmitted infections with Chlamydia trachomatis or Neisseria gonorrhoeae. 1

Primary Mechanism: Ascending Infection

The pathogenesis follows a clear progression:

• Initial cervical infection: N. gonorrhoeae and C. trachomatis establish endocervicitis as the starting point 1
• Upward migration: Bacteria ascend through the endocervical canal to reach the endometrial lining and fallopian tube mucosa 1
• Clinical manifestation: Between 10-40% of women with untreated gonococcal or chlamydial cervicitis develop symptomatic acute PID 1
• Subclinical disease: Even higher percentages show evidence of ascending infection when endometrial biopsies are performed, indicating many cases progress silently 1

Alternative pathway: Noncanalicular spread can occur via parametrial lymphatics, though this is less common 1

Microbial Etiology: Polymicrobial Nature

Most PID cases involve multiple organisms simultaneously 1:

Primary Sexually Transmitted Pathogens

• C. trachomatis: Recovered from cervix in 5-39% of PID cases 1
• N. gonorrhoeae: Isolated from cervix in 27-80% of cases 1

Secondary Polymicrobial Infection

After initial STI-mediated ascent, 25-50% of acute PID cases show colonization with:

• Anaerobes: Bacteroides, Peptostreptococcus, Peptococcus species 1
• Facultative bacteria: Gardnerella vaginalis, Streptococcus species, E. coli, H. influenzae 1
• Bacterial vaginosis organisms: BV has been identified as an antecedent condition that facilitates polymicrobial acute PID 1, 2

Four Key Contributing Factors to Bacterial Ascent

1 identify specific mechanisms that facilitate upward spread:

1. Uterine instrumentation: IUD insertion physically disrupts barriers and introduces vaginal/cervical bacteria into the upper tract 1

2. Menstrual-related changes:

   • Hormonal fluctuations alter cervical mucus consistency
   • Loss of mechanical cervical barrier during menses
   • Bacteriostatic effect of cervical mucus reaches its lowest point at menses onset 1

3. Retrograde menstruation: Backward flow of menstrual blood carries bacteria to tubes and peritoneum 1

4. Organism virulence factors: Individual bacterial strains possess specific characteristics that enhance their ability to invade upper genital tract tissues 1

Clinical Progression and Sequelae

The critical window: Without treatment, cervical infections progress to upper tract disease within weeks to months, with 10-40% developing symptomatic PID 1. The remaining cases may develop "silent PID" with minimal or no symptoms, yet still sustain tubal damage leading to infertility, ectopic pregnancy, and chronic pelvic pain 1.

Important Clinical Caveats

• Subclinical disease is common: Many women show serologic evidence of past chlamydial infection and tubal damage without recalling symptomatic illness 1
• Polymicrobial evolution: Even when STIs initiate the process, secondary colonization with anaerobes and other bacteria complicates the infection 1, 2
• Emerging pathogens: Mycoplasma genitalium is increasingly recognized as a causative agent, though its exact role remains under investigation 3, 4

The key to preventing PID-related morbidity (infertility, ectopic pregnancy, chronic pain) is early detection and treatment of lower genital tract STIs before ascending infection occurs 1.